Cargando…

(18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment

BACKGROUND: Differentiating pulmonary metastasis from primary lung cancer can be challenging in patients with breast malignancy. This study aimed to characterize the imaging features of (18)fluorodeoxyglucose‐positron emission tomography/computed tomography ((18)F‐FDG‐PET/CT) for distinguishing betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lei, Bian, Haiman, Yang, Lieming, Liu, Jianjing, Chen, Wei, Li, Xiaofeng, Wang, Jian, Song, Xiuyu, Dai, Dong, Ye, Zhaoxiang, Xu, Wengui, Yu, Xiaozhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500976/
https://www.ncbi.nlm.nih.gov/pubmed/30900387
http://dx.doi.org/10.1111/1759-7714.13049
_version_ 1783416039045857280
author Zhu, Lei
Bian, Haiman
Yang, Lieming
Liu, Jianjing
Chen, Wei
Li, Xiaofeng
Wang, Jian
Song, Xiuyu
Dai, Dong
Ye, Zhaoxiang
Xu, Wengui
Yu, Xiaozhou
author_facet Zhu, Lei
Bian, Haiman
Yang, Lieming
Liu, Jianjing
Chen, Wei
Li, Xiaofeng
Wang, Jian
Song, Xiuyu
Dai, Dong
Ye, Zhaoxiang
Xu, Wengui
Yu, Xiaozhou
author_sort Zhu, Lei
collection PubMed
description BACKGROUND: Differentiating pulmonary metastasis from primary lung cancer can be challenging in patients with breast malignancy. This study aimed to characterize the imaging features of (18)fluorodeoxyglucose‐positron emission tomography/computed tomography ((18)F‐FDG‐PET/CT) for distinguishing between these diseases. METHODS: We enrolled 52 patients who received curative treatment for breast cancer but later presented with suspected solitary pulmonary lesions (SPLs) and subsequently underwent (18)F‐FDG‐PET/CT to investigate. RESULTS: Subsolid lesions, ill‐defined borders, lung lesions with negative maximum standardized uptake value, and lesions without (18)F‐FDG‐PET/CT‐diagnosed hilar and/or mediastinal lymph nodes and pleural metastases were more likely to be associated with primary lung cancer. CONCLUSIONS: CT border, FDG uptake, hilar and/or mediastinal lymph node metastasis, and pleural metastasis are potential markers for diagnosis.
format Online
Article
Text
id pubmed-6500976
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-65009762019-05-10 (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment Zhu, Lei Bian, Haiman Yang, Lieming Liu, Jianjing Chen, Wei Li, Xiaofeng Wang, Jian Song, Xiuyu Dai, Dong Ye, Zhaoxiang Xu, Wengui Yu, Xiaozhou Thorac Cancer Original Articles BACKGROUND: Differentiating pulmonary metastasis from primary lung cancer can be challenging in patients with breast malignancy. This study aimed to characterize the imaging features of (18)fluorodeoxyglucose‐positron emission tomography/computed tomography ((18)F‐FDG‐PET/CT) for distinguishing between these diseases. METHODS: We enrolled 52 patients who received curative treatment for breast cancer but later presented with suspected solitary pulmonary lesions (SPLs) and subsequently underwent (18)F‐FDG‐PET/CT to investigate. RESULTS: Subsolid lesions, ill‐defined borders, lung lesions with negative maximum standardized uptake value, and lesions without (18)F‐FDG‐PET/CT‐diagnosed hilar and/or mediastinal lymph nodes and pleural metastases were more likely to be associated with primary lung cancer. CONCLUSIONS: CT border, FDG uptake, hilar and/or mediastinal lymph node metastasis, and pleural metastasis are potential markers for diagnosis. John Wiley & Sons Australia, Ltd 2019-03-21 2019-05 /pmc/articles/PMC6500976/ /pubmed/30900387 http://dx.doi.org/10.1111/1759-7714.13049 Text en © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Zhu, Lei
Bian, Haiman
Yang, Lieming
Liu, Jianjing
Chen, Wei
Li, Xiaofeng
Wang, Jian
Song, Xiuyu
Dai, Dong
Ye, Zhaoxiang
Xu, Wengui
Yu, Xiaozhou
(18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title_full (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title_fullStr (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title_full_unstemmed (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title_short (18)Fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
title_sort (18)fluorodeoxyglucose‐positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500976/
https://www.ncbi.nlm.nih.gov/pubmed/30900387
http://dx.doi.org/10.1111/1759-7714.13049
work_keys_str_mv AT zhulei 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT bianhaiman 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT yanglieming 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT liujianjing 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT chenwei 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT lixiaofeng 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT wangjian 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT songxiuyu 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT daidong 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT yezhaoxiang 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT xuwengui 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment
AT yuxiaozhou 18fluorodeoxyglucosepositronemissiontomographycomputedtomographyfeaturesofsuspectedsolitarypulmonarylesionsinbreastcancerpatientsfollowingpreviouscurativetreatment